The In Vitro Toxicity Testing Market, estimated at USD 10.04 Bn in 2025, is expected to exhibit a CAGR of 13.5% and reach USD 24.36 Bn by 2032.
The market growth is driven by rising demand for accurate and early disease detection, supported by advances in molecular diagnostics, imaging, and point-of-care testing. Growing focus on personalized medicine, supportive healthcare policies, and ongoing R&D investments are creating new opportunities for industry players.
increasing research and development activities by the research institutes in the market is expected to drive the market growth over the forecast period. For instance, in an article published on September 17, 2025, in the peer-reviewed journal Environment International, Lisa Zimmermann and colleagues from the Goethe University Frankfurt am Main, Germany, and Norwegian University of Science and Technology, Trondheim, Norway, revealed that two-thirds (67%) of the samples caused adverse reactions when tested for in vitro toxicity and chemical composition of extracts from bioplastics and plant-based materials used in food contact baseline toxicity, 42% oxidative stress, 23 % antiandrogenicity and one sample estrogenicity.” The single estrogenic sample was a Polylactic Acid (PLA) film.
Global In Vitro Toxicity Testing Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.There were three main ways that COVID-19 influenced the economy: directly by impacting supply and demand, indirectly by disrupting distribution networks, and economically by having an effect on businesses and financial markets.
Though COVID-19 pandemic had positive impact on global in vitro toxicity testing market owing to increasing adoption of invitro toxicity assessment test. For instance, an article published by National Center for Biotechnology Information (NCBI), on December 24, 2025, stated that since Since the COVID-19 outbreak, there has been more attention paid to how environmental factors impact an organism's immune system since they may combine with viruses to damage that organism's defences. Immunotoxicity is considered in environmental risk assessments because it has the potential to be the first sign of other toxic consequences because the immune system is more susceptible to it. The immunotoxicity test for environmental contaminants faces more difficulties than other toxicity endpoints such as genotoxicity, endocrine toxicity, or developmental toxicity, as a result of lack of comprehensive mechanisms of action and trustworthy testing techniques.